
Trump Threatens 100% Tariffs on Patented Drugs Unless Firms Build U.S. Plants
Published September 26, 2025
Share this card
A satirical card depicting the dramatic ultimatum: 100% tariffs on branded drug imports unless pharmaceutical firms break ground on U.S. factories, showing collapsing foreign drugmakers and frantic domestic build efforts.
Trump announced that starting October 1, the U.S. will impose a 100% tariff on imported branded or patented pharmaceutical products, unless the companies are actively building manufacturing plants in the U.S. The exemption applies only to firms that are already “breaking ground” or “under construction.” Generic drugs aren’t included in the measure. The move is intended to force onshoring of drug production and reduce reliance on foreign pharmaceutical imports.
Read the original article →France Bans Social Media for Kids Under 15
Jul 23, 2026
US Military Completes 11th Night of Strikes on Iran Amid Escalating Tensions
Jul 22, 2026
US Passport Power Plummets in Global Ranking
Jul 22, 2026
Hunter Biden Criticizes D.C.'s 'Closeted Gay Mafia'
Jul 21, 2026